INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 172 filers reported holding INTERSECT ENT INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,988,000 | +54.7% | 528,404 | +35.6% | 0.07% | +29.1% |
| Q4 2018 | $10,980,000 | +41.7% | 389,624 | +44.5% | 0.06% | +103.7% |
| Q3 2018 | $7,751,000 | -9.8% | 269,614 | +17.5% | 0.03% | -15.6% |
| Q2 2018 | $8,593,000 | +120.7% | 229,463 | +131.6% | 0.03% | +113.3% |
| Q1 2018 | $3,893,000 | – | 99,071 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |